The New Alzheimer’s Drug That Could Break Medicare

The New Alzheimer’s Drug That Could Break Medicare
(Biogen via AP)
Patients are desperate for hope. But there are serious concerns about Biogen’s new $56,000 treatment. Read Full Article »


Comment
Show comments Hide Comments


Related Articles

Market Overview
Search Stock Quotes